NeuBase Therapeutics Inc (NBSE)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
NeuBase Therapeutics 1 Year Total Returns (Daily): -90.00% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -90.00% |
May 20, 2024 | -90.00% |
May 17, 2024 | -90.25% |
May 16, 2024 | -89.87% |
May 15, 2024 | -90.21% |
May 14, 2024 | -90.27% |
May 13, 2024 | -90.27% |
May 10, 2024 | -90.05% |
May 09, 2024 | -89.60% |
May 08, 2024 | -89.23% |
May 07, 2024 | -89.18% |
May 06, 2024 | -88.91% |
May 03, 2024 | -88.23% |
May 02, 2024 | -85.33% |
May 01, 2024 | -85.19% |
April 30, 2024 | -84.61% |
April 29, 2024 | -84.51% |
April 26, 2024 | -82.96% |
April 25, 2024 | -83.17% |
April 24, 2024 | -85.12% |
April 23, 2024 | -86.21% |
April 22, 2024 | -86.25% |
April 19, 2024 | -88.06% |
April 18, 2024 | -86.80% |
April 17, 2024 | -87.27% |
Date | Value |
---|---|
April 16, 2024 | -88.04% |
April 15, 2024 | -87.58% |
April 12, 2024 | -87.47% |
April 11, 2024 | -88.09% |
April 10, 2024 | -87.84% |
April 09, 2024 | -88.33% |
April 08, 2024 | -87.97% |
April 05, 2024 | -88.02% |
April 04, 2024 | -87.61% |
April 03, 2024 | -87.55% |
April 02, 2024 | -88.49% |
April 01, 2024 | -88.11% |
March 28, 2024 | -87.07% |
March 27, 2024 | -87.92% |
March 26, 2024 | -86.08% |
March 25, 2024 | -70.93% |
March 22, 2024 | -72.64% |
March 21, 2024 | -71.67% |
March 20, 2024 | -71.24% |
March 19, 2024 | -73.18% |
March 18, 2024 | -73.70% |
March 15, 2024 | -74.13% |
March 14, 2024 | -77.80% |
March 13, 2024 | -76.95% |
March 12, 2024 | -76.25% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.98%
Minimum
Aug 15 2023
318.6%
Maximum
Dec 31 2019
-15.49%
Average
-59.03%
Median
Nov 12 2021
1 Year Total Returns (Daily) Benchmarks
Ampio Pharmaceuticals Inc | -95.49% |
Stoke Therapeutics Inc | 36.81% |
ABVC BioPharma Inc | -85.20% |
MAIA Biotechnology Inc | 49.59% |
Aprea Therapeutics Inc | 32.91% |